Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6

Jeffrey M. Trent, Eric J. Stanbridge, Heyoung L. McBride, Eckart U. Meese, Graham Casey, Dnia E. Araujo, Colette M. Witkowski, Raymond B. Nagle

Research output: Contribution to journalArticle

304 Scopus citations

Abstract

Chromosome banding analysis of human malignant melanoma has documented the nonrandom alteration of chromosome 6. To determine the relevance of chromosome 6 abnormalities in melanoma, a normal chromosome 6 was directly introduced into melanoma cell lines. The resulting (+6) microcell hybrids were significantly altered in their phenotypic properties in culture and lost their ability to form tumors in nude mice. The loss of the chromosome 6 from melanoma microcell hybrids resulted in the reversion to tumorigenicity of these cells in mice. The introduction of the selectable marker (psv2neo) alone into melanoma cell lines had no effect on tumorigenicity. These results support the idea that one or more genes on chromosome 6 may control the malignant expression of human melanoma.

Original languageEnglish (US)
Pages (from-to)568-571
Number of pages4
JournalScience
Volume247
Issue number4942
DOIs
StatePublished - Jan 1 1990

ASJC Scopus subject areas

  • General

Fingerprint Dive into the research topics of 'Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6'. Together they form a unique fingerprint.

  • Cite this

    Trent, J. M., Stanbridge, E. J., McBride, H. L., Meese, E. U., Casey, G., Araujo, D. E., Witkowski, C. M., & Nagle, R. B. (1990). Tumorigenicity in human melanoma cell lines controlled by introduction of human chromosome 6. Science, 247(4942), 568-571. https://doi.org/10.1126/science.2300817